Matches in Wikidata for { <http://www.wikidata.org/entity/Q73893052> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q73893052 description "article scientifique publié en 1997" @default.
- Q73893052 description "artículu científicu espublizáu en payares de 1997" @default.
- Q73893052 description "bài báo khoa học" @default.
- Q73893052 description "im November 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73893052 description "scientific article published on 01 November 1997" @default.
- Q73893052 description "wetenschappelijk artikel" @default.
- Q73893052 description "наукова стаття, опублікована в листопаді 1997" @default.
- Q73893052 name "Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?" @default.
- Q73893052 name "Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?" @default.
- Q73893052 type Item @default.
- Q73893052 label "Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?" @default.
- Q73893052 label "Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?" @default.
- Q73893052 prefLabel "Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?" @default.
- Q73893052 prefLabel "Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?" @default.
- Q73893052 P1433 Q73893052-23F7F9E8-AF55-42E2-BF63-CCE9FCEF2A5B @default.
- Q73893052 P1476 Q73893052-0D302896-8676-4B46-BD70-56BBA9C49114 @default.
- Q73893052 P2093 Q73893052-4E63C2A3-779E-4AFD-880A-E68B641DB870 @default.
- Q73893052 P2093 Q73893052-77207433-84F7-4684-B68D-FC35373FE596 @default.
- Q73893052 P2093 Q73893052-AACF950A-CA9D-43E0-8826-C36DB105AF5A @default.
- Q73893052 P2093 Q73893052-C684D511-D054-4674-9682-A1602B986BAD @default.
- Q73893052 P2093 Q73893052-C7C7A014-65B1-44AA-8FBC-DC4AC9720CD1 @default.
- Q73893052 P304 Q73893052-D21E0D10-A105-4F9A-9D0E-725A28CE618F @default.
- Q73893052 P31 Q73893052-61E19257-CC76-46F1-9248-6DD325622EE8 @default.
- Q73893052 P407 Q73893052-96FCF424-B591-4947-A9DA-759DD1525662 @default.
- Q73893052 P433 Q73893052-0DFC6ADE-27F0-489C-9F49-BD7C362C2D07 @default.
- Q73893052 P478 Q73893052-BB267013-993B-40E6-835C-D5E782D5D3BA @default.
- Q73893052 P577 Q73893052-EDE53BFC-208D-4A53-9B5F-A2C165CC5E87 @default.
- Q73893052 P698 Q73893052-C01EC782-3822-4DF6-B657-41806690FAE4 @default.
- Q73893052 P921 Q73893052-8276F91C-7783-484E-A30E-AB9A2838018D @default.
- Q73893052 P698 9375777 @default.
- Q73893052 P1433 Q4970200 @default.
- Q73893052 P1476 "Should patients starting anticoagulant therapy be screened for missense mutations at Ala-10 in the factor IX propeptide?" @default.
- Q73893052 P2093 "Baglin C" @default.
- Q73893052 P2093 "Baglin T" @default.
- Q73893052 P2093 "Brown K" @default.
- Q73893052 P2093 "Luddington R" @default.
- Q73893052 P2093 "Peters J" @default.
- Q73893052 P304 "467-468" @default.
- Q73893052 P31 Q13442814 @default.
- Q73893052 P407 Q1860 @default.
- Q73893052 P433 "2" @default.
- Q73893052 P478 "99" @default.
- Q73893052 P577 "1997-11-01T00:00:00Z" @default.
- Q73893052 P698 "9375777" @default.
- Q73893052 P921 Q215118 @default.